Evidence map›Paper›PMID 33732281›Full record

ArticleFrontiers in genetics2021

Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer.

Hongxian Zhang, Jiwen Song, Junqiang Dong, Zhuo Liu, Lixuan Lin, Bing Wang, Qiang Ma, Lulin Ma

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 1 country.

Hongxian ZhangDepartment of Urology, Peking University Third Hospital, Beijing, China.
Jiwen SongDepartment of Urology, Shanxi Provincial Cancer Hospital, Taiyuan, China.
Junqiang DongDepartment of Urology, Heze Municipal Hospital, Heze, China.
Zhuo LiuDepartment of Urology, Peking University Third Hospital, Beijing, China.
Lixuan LinDepartment of Biotechnology, College of Life Sciences, Sichuan University, Chengdu, China.
Bing WangDepartment of Oncology, Wuhan No.1 Hospital, Wuhan, China.
Qiang MaDepartment of Oncology, People's Hospital of Xintai City, Xintai, China.
Lulin MaDepartment of Urology, Peking University Third Hospital, Beijing, China.
Peking University · CNHeze Municipal Hospital · CNPeking University Third Hospital · CNShanxi Provincial Cancer Hospital · CNSichuan University · CNWuhan No.1 Hospital · CNXintai People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bladder cancercopy number variationdifferentially expressed genesimmune cellsimmune checkpoint inhibitorsoverall survivalsomatic mutationtumor microenvironment

Identifiers

PMID33732281
PMCPMC7957069
OpenAlexW3134677330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.